about
Real-time color-flow CMR in adults with congenital heart disease.Identifying cardiac transplant rejection in children: diagnostic utility of echocardiography, right heart catheterization and endomyocardial biopsy data.Adverse events in children implanted with ventricular assist devices in the United States: Data from the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS).Abdominal complaints as a common first presentation of heart failure in adolescents with dilated cardiomyopathy.QRS prolongation is strongly associated with life-threatening ventricular arrhythmias in children with dilated cardiomyopathy.Reliability of echocardiographic measurements of left ventricular systolic function in potential pediatric heart transplant donors.Comparison of the epidemiology and co-morbidities of heart failure in the pediatric and adult populations: a retrospective, cross-sectional study.Neurological complications and outcomes in the Berlin Heart EXCOR® pediatric investigational device exemption trial.New developments in echocardiographic methods to assess right ventricular function in congenital heart disease.Indications for heart transplantation in pediatric heart disease: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and CardiovascuMonitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group.Magnetic resonance imaging of the right ventricle in pediatric pulmonary arterial hypertensionChildren with pulmonary arterial hypertension and prostanoid therapy: long-term hemodynamics.Cardiac findings in congenital muscular dystrophies.Outpatient management of pediatric heart failure.Implementation of a comprehensive interdisciplinary care coordination of infants and young children on Berlin Heart ventricular assist devices.Berlin Heart EXCOR Pediatric ventricular assist device Investigational Device Exemption study: study design and rationale.End-stage renal disease and cardiomyopathy in children: cardiac effects of renal transplantation.Outcomes of children following a first hospitalization for dilated cardiomyopathy.Lower socioeconomic status is associated with worse outcomes after both listing and transplanting children with heart failure.In-hospital arrhythmia development and outcomes in pediatric patients with acute myocarditis.An inpatient rehabilitation program utilizing standardized care pathways after paracorporeal ventricular assist device placement in children.Carvedilol for children and adolescents with heart failure: a randomized controlled trial.Impact of the 18th birthday on waitlist outcomes among young adults listed for heart transplant: A regression discontinuity analysis.Electrocardiographic repolarization abnormalities and increased risk of life-threatening arrhythmias in children with dilated cardiomyopathy.Development and validation of a major adverse transplant event (MATE) score to predict late graft loss in pediatric heart transplantation.Functional status of United States children supported with a left ventricular assist device at heart transplantation.Impact of Heart Transplantation on the Functional Status of US Children With End-Stage Heart Failure.Rehospitalization after pediatric heart transplantation: Incidence, indications, and outcomes.Superior performance of continuous over pulsatile flow ventricular assist devices in the single ventricle circulation: A computational study.Hot topics in tetralogy of Fallot.Does Small Size Matter With Continuous Flow Devices?: Analysis of the INTERMACS Database of Adults With BSA ≤1.5 m2.Outcomes of children implanted with ventricular assist devices in the United States: First analysis of the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS).Outpatient Outcomes of Pediatric Patients with Left Ventricular Assist Devices.A Pilot Study Assessing ECG versus ECHO Ventriculoventricular Optimization in Pediatric Resynchronization Patients.Rehospitalization Patterns in Pediatric Outpatients with Continuous-Flow VADs.Group visits in the pediatric heart transplant outpatient clinic.HeartWare HVAD for Biventricular Support in Children and Adolescents: The Stanford Experience.Outcomes of pediatric patients supported with continuous-flow ventricular assist devices: A report from the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS).Impact of ventricular assist device placement on longitudinal renal function in children with end-stage heart failure.
P50
Q30399380-FC5EA824-6CDE-4283-AF00-3AEBDAE75126Q30912300-5E24535D-945B-42E1-8ED5-F5D7DFEF2930Q31097428-F669211D-DCA3-4AE9-BE71-393897887748Q33162331-68174FE8-FC39-42EF-A27F-5A894FF1AC5BQ33163137-E0DA01A0-49EA-4408-B390-4CF306E150CDQ34785108-E29FD5F6-5212-4E93-8AA4-0D35810F3436Q34945026-6DE7C1B3-D99A-423D-98CF-D3580F702B2BQ35088137-9099B761-1389-4303-A8E4-798ADA28C8F6Q36041871-54BF8CC3-B74C-441C-A1EA-C5394961D8A1Q36721561-A5FE1385-8364-46F2-8E18-00355CB76E57Q37054768-3EFC44B3-A88E-4AB0-9F4E-5909C34227ACQ37133801-001D7337-AEAD-4E81-989B-DEF74C54608EQ37139801-21BBE962-F035-42B9-BB1A-7654662A349DQ37777261-A6B1D79B-7DB4-48B4-8B30-E57077524C36Q37792406-D1454B07-480C-4E6A-B1B1-EDDF306BC68CQ37811794-3523638B-E6BD-4941-BA83-521FBA9E553DQ37925198-1D3A52BB-9B50-4254-A359-DC8118E4A975Q37965315-DEE59468-5A07-422A-BAAB-14A4B15611C7Q38008620-0D39E6BC-7003-48A0-82B9-D71C690B260BQ38120072-5D12678F-B34A-4EF2-A3EF-75804B5EFD90Q38170760-275F8110-0747-4D50-B42E-B538898484ADQ38182214-487C5880-C517-46AF-BE41-ADC8D4E36D49Q38395213-8C990FEC-80C6-46D4-ABC5-76C1F7E6166FQ38676828-B06765F7-99B9-464D-B774-80C9F0C27A34Q38762006-E84E36EC-04DC-4F32-87C6-CE91F40F7639Q38808221-9D1B4992-D922-4363-8A70-06D8E36E6320Q38864032-CC4E7DBD-A6D8-4173-BABA-A1877EE46916Q39001183-1CBC9914-CB2D-496F-9814-F8A28E885804Q39021846-AF578DA1-40AE-4AFA-BD20-17CD2993D2D6Q39049999-1333DB33-8F51-44F2-B3AC-2EC1AB83DDC0Q39200348-BFF3BE5C-4B9B-4DEE-9B4A-5BEE5B07DD36Q39212572-9C196D4F-9AB5-4DD0-9151-69E2AE219019Q39892820-D1C836CC-7022-4F80-BA4B-90F4E7C81413Q40154952-2047C170-3246-4F73-B75C-7299D710B937Q40377578-A5EAE579-1C52-4D93-A532-09236C446885Q40397676-A39301BD-8B0A-4546-A1F1-EF340F6BD72FQ40650581-1A17EE3D-E590-4557-9DF0-7AFB064846E4Q40776208-FBC9EA90-22F1-4AF0-AF1E-22A6C3CE656EQ40812004-67E737DB-D622-48A7-99C3-72D8A50066F0Q41062226-0F3282F1-4647-4273-A6EB-8D07C250C824
P50
description
Forscher
@de
investigador
@es
onderzoeker
@nl
researcher
@en
ricercatore
@it
研究員
@ja
研究者
@zh
name
David N Rosenthal
@en
David N Rosenthal
@nl
type
label
David N Rosenthal
@en
David N Rosenthal
@nl
prefLabel
David N Rosenthal
@en
David N Rosenthal
@nl
P106
P31
P496
0000-0002-6342-2759